Patent · US Active

Dsg2 monoclonal antibody and the applications thereof

US10836823B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignee

ASCLEPIUMM TAIWAN CO., LTD · TW

Inventors

Min-Che Chen · Amherst, US
Po-Hao Chang · Kaohsiung, TW
Ya-chuan Liu · New Taipei, TW

Key dates

Filing date	Jun 6, 2016
Grant date	Nov 17, 2020
Priority date	—
Expiry date	Jun 6, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/85
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides antibodies against the antigen containing the Dsg2 extracellular domain 2. Also provided is the method of using the antibodies in treatment or prevention of a cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.